BRPI0414512A - reprodução de imagens e terapia de células beta pancreáticas, direcionadas por um mecanismo - Google Patents
reprodução de imagens e terapia de células beta pancreáticas, direcionadas por um mecanismoInfo
- Publication number
- BRPI0414512A BRPI0414512A BRPI0414512-7A BRPI0414512A BRPI0414512A BR PI0414512 A BRPI0414512 A BR PI0414512A BR PI0414512 A BRPI0414512 A BR PI0414512A BR PI0414512 A BRPI0414512 A BR PI0414512A
- Authority
- BR
- Brazil
- Prior art keywords
- pancreatic beta
- cell imaging
- therapy directed
- compositions
- therapy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Optics & Photonics (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrrole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
"REPRODUçãO DE IMAGENS E TERAPIA DE CéLULAS BETA PANCREáTICAS, DIRECIONADAS POR UM MECANISMO". A presente invenção refere-se a composições para reproduzir imagens de células beta, sendo que as composições compreendem conjugados de quelante/agente antidiabético, e opcionalmente, metais quelados.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US50368303P | 2003-09-17 | 2003-09-17 | |
US60/503.683 | 2003-09-17 | ||
PCT/US2004/030374 WO2005027981A1 (en) | 2003-09-17 | 2004-09-16 | Mechanism-based targeted pancreatic beta cell imaging and therapy |
Publications (3)
Publication Number | Publication Date |
---|---|
BRPI0414512A true BRPI0414512A (pt) | 2006-11-07 |
BRPI0414512B1 BRPI0414512B1 (pt) | 2020-11-17 |
BRPI0414512B8 BRPI0414512B8 (pt) | 2021-05-25 |
Family
ID=34375381
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0414512A BRPI0414512B8 (pt) | 2003-09-17 | 2004-09-16 | composição para reproduzir imagens de um pâncreas e uso desta |
Country Status (16)
Country | Link |
---|---|
US (2) | US7611693B2 (pt) |
EP (2) | EP1675625B1 (pt) |
JP (3) | JP5395327B2 (pt) |
KR (2) | KR20110119813A (pt) |
CN (1) | CN1867363B (pt) |
AU (1) | AU2004273911B2 (pt) |
BR (1) | BRPI0414512B8 (pt) |
CA (1) | CA2539384C (pt) |
DK (1) | DK1675625T3 (pt) |
ES (1) | ES2403378T3 (pt) |
HK (1) | HK1094312A1 (pt) |
IL (1) | IL174374A (pt) |
NO (1) | NO336658B1 (pt) |
PL (1) | PL1675625T3 (pt) |
PT (1) | PT1675625E (pt) |
WO (1) | WO2005027981A1 (pt) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7611693B2 (en) * | 2003-09-17 | 2009-11-03 | Board Of Regents, The Univerisity Of Texas System | Mechanism-based targeted pancreatic beta cell imaging and therapy |
WO2006104401A1 (en) * | 2005-03-26 | 2006-10-05 | Protemix Corporation Limited | Copper antagonist compositions |
AU2006266229B2 (en) * | 2005-06-29 | 2013-02-21 | The Trustees Of Columbia University In The City Of New York | Use of DTBZ for imaging endocrine pancreas and beta cell mass in type 1 diabetes |
WO2008038302A2 (en) * | 2006-09-26 | 2008-04-03 | Jegannathan Srinivas | Therapeutic formulation comprising a sulfonylurea, metformin and a nitric oxide scavenger. |
WO2008038304A2 (en) * | 2006-09-26 | 2008-04-03 | Jegannathan Srinivas | Therapeutical formulation comprising an alpha-glucosidase inhibitor and a nitric oxide scavenger. |
CA2719623A1 (en) | 2008-03-24 | 2009-10-01 | The Board Of Regents Of The University Of Texas System | Image-guided therapy of myocardial disease: composition, manufacturing and applications |
EP2460542A4 (en) * | 2009-07-31 | 2015-02-18 | Riken | ENDOKRINER PANCREAS CELL INDICATOR AND ITS USE |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2951135A1 (de) | 1979-12-19 | 1981-06-25 | Hoechst Ag, 6230 Frankfurt | Sulfonylharnstoffe, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung |
JPS57102820A (en) | 1980-12-19 | 1982-06-26 | Nippon Mejifuijitsukusu Kk | Agent for radiodiagnosis |
JPS5944329A (ja) | 1982-09-07 | 1984-03-12 | Nippon Mejifuijitsukusu Kk | 新規な放射性診断剤 |
JPS59193833A (ja) | 1983-04-19 | 1984-11-02 | Nippon Mejifuijitsukusu Kk | 新規な二官能配位子化合物含有放射性診断剤 |
US4732864A (en) | 1983-10-06 | 1988-03-22 | E. I. Du Pont De Nemours And Company | Trace-labeled conjugates of metallothionein and target-seeking biologically active molecules |
JPS6354321A (ja) | 1985-03-27 | 1988-03-08 | Ajinomoto Co Inc | 血糖降下剤 |
JPH01186899A (ja) * | 1988-01-18 | 1989-07-26 | Nippon Mejifuijitsukusu Kk | 膜透過性を有するTc−99m単核錯体 |
MY106120A (en) * | 1988-12-05 | 1995-03-31 | Novartis Ag | Peptide derivatives. |
US5094837A (en) | 1990-01-22 | 1992-03-10 | Wayne State University | Method for use of magnetic resonance imaging to image pancreas using secretin |
US4994258A (en) | 1990-03-05 | 1991-02-19 | Merck & Co., Inc. | Gamma emitting, CCK-A antagonists for pancreatic imaging |
FR2661187B1 (fr) | 1990-04-20 | 1994-08-05 | Inst Nat Sante Rech Med | Proteine associee a la pancreatite aiguue. moyens pour le diagnostic de la pancreatite aiguue. |
JPH05186372A (ja) | 1991-07-18 | 1993-07-27 | Green Cross Corp:The | 脂肪乳剤及びmri診断用造影剤 |
US5463116A (en) | 1991-07-30 | 1995-10-31 | Ajinomoto Co., Inc. | Crystals of N- (trans-4-isopropylcyclohexlycarbonyl)-D-phenylalanine and methods for preparing them |
JP3465247B2 (ja) | 1992-12-28 | 2003-11-10 | アベンティス ファーマ株式会社 | 動脈硬化症の予防および治療剤 |
US5656600A (en) * | 1993-03-25 | 1997-08-12 | Corvas International, Inc. | α-ketoamide derivatives as inhibitors of thrombosis |
US5879657A (en) * | 1993-03-30 | 1999-03-09 | The Dupont Merck Pharmaceutical Company | Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders |
DE4336159A1 (de) | 1993-10-22 | 1995-04-27 | Kurt Heinz Prof Dr Bauer | Hochwirksame, den Wirkstoff schnell oder kontrolliert freisetzende Zubereitungsformen von Sulfonylharnstoffen und Verfahren zu deren Herstellung |
US5763200A (en) * | 1995-05-12 | 1998-06-09 | Biomeasure, Incorporated | Inhibition of amylin release |
WO1998033531A1 (en) * | 1997-02-03 | 1998-08-06 | Mallinckrodt Medical, Inc. | Method for the detection and localization of malignant human tumours |
WO2000023603A2 (en) | 1998-10-21 | 2000-04-27 | Arch Development Corporation | Methods of treatment of type 2 diabetes |
US6358491B1 (en) * | 1999-08-27 | 2002-03-19 | Berlex Laboratories, Inc. | Somatostatin analogs |
JP4822039B2 (ja) * | 1999-12-28 | 2011-11-24 | 味の素株式会社 | 経口投与用糖尿病薬製剤 |
SK14922002A3 (sk) * | 2000-03-17 | 2003-04-01 | Ajinomoto Co., Inc. | Farmaceutický prostriedok na prevenciu, zlepšenie a/alebo liečenie diabetickej komplikácie a použitie postprandiálnej látky na zníženie hladiny krvného cukru |
AU2001285145A1 (en) | 2000-08-21 | 2002-03-04 | Millennium Pharmaceuticals, Inc. | Human abc transporter family member and uses thereof |
AU2002338572A1 (en) | 2001-04-13 | 2002-11-11 | Millennium Pharmaceuticals, Inc. | 66784, a novel human potassium channel and uses therefor |
US7611693B2 (en) * | 2003-09-17 | 2009-11-03 | Board Of Regents, The Univerisity Of Texas System | Mechanism-based targeted pancreatic beta cell imaging and therapy |
-
2004
- 2004-09-16 US US10/942,615 patent/US7611693B2/en active Active
- 2004-09-16 PT PT47888003T patent/PT1675625E/pt unknown
- 2004-09-16 JP JP2006527025A patent/JP5395327B2/ja active Active
- 2004-09-16 PL PL04788800T patent/PL1675625T3/pl unknown
- 2004-09-16 DK DK04788800.3T patent/DK1675625T3/da active
- 2004-09-16 EP EP04788800A patent/EP1675625B1/en active Active
- 2004-09-16 AU AU2004273911A patent/AU2004273911B2/en active Active
- 2004-09-16 CA CA2539384A patent/CA2539384C/en active Active
- 2004-09-16 ES ES04788800T patent/ES2403378T3/es active Active
- 2004-09-16 KR KR1020117021985A patent/KR20110119813A/ko not_active Application Discontinuation
- 2004-09-16 KR KR1020067005445A patent/KR101152729B1/ko active IP Right Grant
- 2004-09-16 CN CN2004800300890A patent/CN1867363B/zh active Active
- 2004-09-16 EP EP11188976A patent/EP2474328A3/en not_active Withdrawn
- 2004-09-16 WO PCT/US2004/030374 patent/WO2005027981A1/en active Application Filing
- 2004-09-16 BR BRPI0414512A patent/BRPI0414512B8/pt active IP Right Grant
-
2006
- 2006-03-16 IL IL174374A patent/IL174374A/en active IP Right Grant
- 2006-04-11 NO NO20061645A patent/NO336658B1/no unknown
- 2006-12-15 HK HK06113846.3A patent/HK1094312A1/xx unknown
-
2009
- 2009-11-02 US US12/610,857 patent/US20100278731A1/en not_active Abandoned
-
2010
- 2010-12-03 JP JP2010270880A patent/JP2011052016A/ja active Pending
-
2014
- 2014-12-17 JP JP2014254707A patent/JP2015078223A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
KR20110119813A (ko) | 2011-11-02 |
CN1867363B (zh) | 2010-05-12 |
EP2474328A2 (en) | 2012-07-11 |
US20100278731A1 (en) | 2010-11-04 |
KR20060104984A (ko) | 2006-10-09 |
NO336658B1 (no) | 2015-10-12 |
US20050100506A1 (en) | 2005-05-12 |
AU2004273911A1 (en) | 2005-03-31 |
JP2015078223A (ja) | 2015-04-23 |
PT1675625E (pt) | 2013-05-23 |
AU2004273911B2 (en) | 2010-04-15 |
PL1675625T3 (pl) | 2013-08-30 |
EP1675625A4 (en) | 2009-07-15 |
NO20061645L (no) | 2006-04-11 |
EP1675625A1 (en) | 2006-07-05 |
KR101152729B1 (ko) | 2012-06-15 |
US7611693B2 (en) | 2009-11-03 |
WO2005027981A1 (en) | 2005-03-31 |
DK1675625T3 (da) | 2013-05-13 |
BRPI0414512B8 (pt) | 2021-05-25 |
JP2007505915A (ja) | 2007-03-15 |
CN1867363A (zh) | 2006-11-22 |
JP5395327B2 (ja) | 2014-01-22 |
EP1675625B1 (en) | 2013-02-20 |
HK1094312A1 (en) | 2007-03-30 |
CA2539384A1 (en) | 2005-03-31 |
ES2403378T3 (es) | 2013-05-17 |
JP2011052016A (ja) | 2011-03-17 |
EP2474328A3 (en) | 2012-07-18 |
CA2539384C (en) | 2012-08-28 |
IL174374A0 (en) | 2006-08-01 |
IL174374A (en) | 2011-12-29 |
BRPI0414512B1 (pt) | 2020-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL176903A0 (en) | Pharmaceutical formulations comprising metformin and a fibrate, and processes for obtaining them | |
BG105568A (en) | Pharmaceutical compositions for modified release of an insulin sensitiser and another antidiabetic agent | |
AR069980A1 (es) | Inmunoconjugados dirigidos contra cd 138 y sus usos | |
TNSN08194A1 (fr) | Compositions pharmaceutiques solides contenant de la pregabaline | |
DE60233234D1 (en) | Sulfoniumsalze als photoinitiatoren für strahlungshärtbare systeme | |
BRPI0515684A (pt) | formulações de cristais injetáveis ativas de longa duração de metabólitos de estradiol, e métodos de utilização das mesmas | |
IL186775A0 (en) | Tgf beta 1 specific antibodies | |
BRPI0507684B8 (pt) | agentes de contraste para imagem de perfusão miocárdica | |
IL145830A0 (en) | Pharmaceutical compositions containing a compound which activates a receptor for glucagon-like peptide-1 | |
WO2001092283A3 (en) | Cobalamin compounds useful as cardiovascular agents and as imaging agents | |
HK1175846A1 (en) | Cytotoxicity mediation of cells evidencing surface expression of cd44 cd44 | |
PE20070363A1 (es) | Complejos metalicos con contenido de perfluoroalquilo como medios de contraste en imagenes de resonancia magnetica y procedimientos para su preparacion | |
BRPI0620229A8 (pt) | formulação | |
GT199900154A (es) | Agentes farmaceuticos para el tratamiento de la enfermedad de parkinson, adhd y microadenomas. | |
BRPI0414512A (pt) | reprodução de imagens e terapia de células beta pancreáticas, direcionadas por um mecanismo | |
BRPI0416528A (pt) | agente de formação de imagem, composição farmacêutica, composição radiofarmacêutica, conjugado, kit para a preparação da composição radiofarmacêutica, e, uso do agente de formação de imagem | |
TW200738239A (en) | Stable solid formulation of sertindole | |
WO2008105808A3 (en) | FORMULATIONS OF RADIOPROTECTIVE α, β UNSATURATED ARYL SULFONES | |
HK1068251A1 (en) | Aminoderivatives of biotin and their conjugates with macrocyclic chelating agents | |
NO20051641L (no) | Improved imaging agents comprising barbituric acid derivatives | |
DK1388542T3 (da) | Anvendelse af hederagenin 3-0-a-L-rhamnopyranosyl((1->2)-[beta-D-glucopyranosyl(1->4)]-a-L-arabinopyranosid eller en ekstrakt fra Pulsatillae radix indeholdende samme som et terapeutisk middel til faste tumorer | |
AR027575A1 (es) | Benzoilciclohexenonas substituidas | |
AR034451A1 (es) | Microcapsulas para la proteccion frente al mal aliento. | |
BR0309023A (pt) | Processo para converter álcoois em compostos de carbonila | |
BRPI0414732A (pt) | piridilacetilenos para uso como radiotraçadores e agentes de imageamento |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 17/11/2020, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 16/09/2004 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |